Study of CS-7017 in Colorectal Cancer Patients Who Have Achieved Disease Control Following First-Line Chemotherapy

ABSTRACT: Monotherapy treatment with CS-7017 to assess progression-free-survival (PFS) of subjects who achieved an objective response of Disease Control on first line therapy with Folinic acid (leucovorin), Fluorouracil (5-FU), Oxaliplatin (Eloxatin) known as FOLFOX; or Folinic acid (leucovorin), Fluorouracil (5-FU), irinotecan (Camptosar) known as FOLFIRI.

DISEASE(S): Colorectal Cancer Stage Iv,Colorectal Cancer,Stage Iii And Iv Colorectal Cancer,Colorectal Neoplasms

PROVIDER: 2078718 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR